tirzepatide patient assistance program eli lilly Is There a Mounjaro Program? China Clears Eli Lilly's Weight

Whether you're accessing a compounded vial for type 2 diabetes or chronic weight management, following correct procedures protects medication integrity and patient safety

The FDA-approved prescribing information does not list protein supplements as incompatible with the medication, and no pharmacokinetic interactions between tirzepatide and dietary protein have been documented

Higher starting BMI predicted greater absolute weight loss but similar percentage reduction

Participants have reported an average weight loss of approximately 19.5% of their initial body weight over 72 weeks

Normal glycemic levels, defined as having an HbA1c of less than 5.7%, were achieved by 46% of adults in the 10 mg tirzepatide group and 48.6% of the 15 mg tirzepatide group compared with 3.9% of those receiving placebo